NCT06501196 2025-09-24A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromeBlossomHill TherapeuticsPhase 1 Recruiting170 enrolled